A detailed history of Aspiriant, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aspiriant, LLC holds 23,211 shares of JNJ stock, worth $3.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
23,211
Previous 21,126 9.87%
Holding current value
$3.6 Million
Previous $3.09 Million 21.83%
% of portfolio
0.14%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$145.48 - $167.38 $303,325 - $348,987
2,085 Added 9.87%
23,211 $3.76 Million
Q2 2024

Jul 15, 2024

SELL
$144.38 - $157.78 $385,927 - $421,745
-2,673 Reduced 11.23%
21,126 $3.09 Million
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $127,435 - $133,609
821 Added 3.57%
23,799 $3.76 Million
Q4 2023

Jan 26, 2024

BUY
$145.6 - $158.88 $25,771 - $28,121
177 Added 0.78%
22,978 $3.6 Million
Q3 2023

Oct 17, 2023

SELL
$155.75 - $174.48 $34,888 - $39,083
-224 Reduced 0.97%
22,801 $3.55 Million
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $44,607 - $48,005
-289 Reduced 1.24%
23,025 $3.81 Million
Q1 2023

Apr 27, 2023

SELL
$151.05 - $180.26 $181,411 - $216,492
-1,201 Reduced 4.9%
23,314 $3.61 Million
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $156,355 - $175,475
976 Added 4.15%
24,515 $0
Q3 2022

Oct 28, 2022

SELL
$161.33 - $179.52 $51,625 - $57,446
-320 Reduced 1.34%
23,539 $3.85 Million
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $142,625 - $157,736
-848 Reduced 3.43%
23,859 $4.23 Million
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $118,763 - $134,872
-751 Reduced 2.95%
24,707 $4.38 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $325,114 - $360,725
2,085 Added 8.92%
25,458 $4.36 Million
Q3 2021

Oct 27, 2021

SELL
$161.5 - $179.47 $63,954 - $71,070
-396 Reduced 1.67%
23,373 $3.77 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $28,706 - $30,792
-180 Reduced 0.75%
23,769 $3.92 Million
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $26,787 - $29,834
175 Added 0.74%
23,949 $3.93 Million
Q4 2020

Feb 01, 2021

SELL
$137.11 - $157.38 $731,481 - $839,622
-5,335 Reduced 18.33%
23,774 $3.74 Million
Q3 2020

Oct 29, 2020

BUY
$140.38 - $153.83 $605,458 - $663,468
4,313 Added 17.39%
29,109 $4.33 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $1.55 Million - $1.87 Million
-12,052 Reduced 32.71%
24,796 $3.49 Million
Q1 2020

May 05, 2020

BUY
$111.14 - $153.99 $1.5 Million - $2.08 Million
13,477 Added 57.67%
36,848 $4.83 Million
Q4 2019

Jan 27, 2020

SELL
$127.5 - $146.44 $655,350 - $752,701
-5,140 Reduced 18.03%
23,371 $3.41 Million
Q3 2019

Nov 04, 2019

SELL
$126.95 - $142.14 $1.57 Million - $1.76 Million
-12,397 Reduced 30.3%
28,511 $3.69 Million
Q2 2019

Aug 06, 2019

SELL
$131.15 - $144.24 $193,052 - $212,321
-1,472 Reduced 3.47%
40,908 $5.69 Million
Q1 2019

May 03, 2019

BUY
$125.72 - $139.79 $1.09 Million - $1.21 Million
8,689 Added 25.79%
42,380 $5.91 Million
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $185,488 - $223,238
-1,510 Reduced 4.29%
33,691 $4.35 Million
Q3 2018

Oct 26, 2018

SELL
$121.58 - $142.88 $1.41 Million - $1.65 Million
-11,567 Reduced 24.73%
35,201 $4.87 Million
Q2 2018

Aug 07, 2018

SELL
$119.4 - $131.76 $279,276 - $308,186
-2,339 Reduced 4.76%
46,768 $5.68 Million
Q1 2018

May 04, 2018

BUY
$125.1 - $148.14 $3.99 Million - $4.72 Million
31,892 Added 185.26%
49,107 $6.29 Million
Q4 2017

Jan 31, 2018

SELL
$131.22 - $143.62 $3.92 Million - $4.29 Million
-29,867 Reduced 63.44%
17,215 $2.41 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $6.1 Million - $6.37 Million
47,082
47,082 $6.12 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.